Viral Clearance Market Size & Share, by Method (Viral Inactivation, Viral Removal); Application (Blood, Recombination, Vaccine); End-user (CROs, Pharmaceuticals, Biotechnology Company) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 3939
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

Viral Clearance Market size is estimated to garner robust revenue by the end of 2033, growing at a CAGR of 20% during the forecast period, i.e., 2023-2033. Further, the market generated impressive revenue in the year 2022. The growth of the market can primarily be attributed to the rising demand for specialty drugs across the globe. For instance, in 2020, the specialty drug expenditure was estimated to hit 8% while in 2019, approximately 3.5% of the global population was projected to take at least 1 specialty drug.

Global market trends such as, rising government initiatives in each country in favor of viral clearance along with spiking penetration of infectious lung diseases and noteworthy growth in healthcare expenditure are projected to influence the growth of the market positively over the forecast period. As per the statistics provided by the World Bank, it was noticed that healthcare expenditure dropped to USD 1,121.9 per capita in 2019. Viral clearance is the difference found between the quantity of virus in the input sample and the fraction containing the product after purification. Moreover, ongoing development in novel technology and rising awareness of viral safety is further expected to flourish the growth of the market over the forecast period. 

Get more information on this report: Request Free Sample PDF

Viral Clearance Market: Key Insights

Base Year


Forecast Year




Get more information on this report: Request Free Sample PDF

Viral Clearance Sector: Growth Drivers and Challenges


Growth Drivers

  • Growing Prevalence of Infectious Diseases to Boost the Market Growth
  • Based on the report provided by the World Health Organization (WHO), it was noticed that around 50,000 people die every day owing to some infectious diseases worldwide.
  • Infectious diseases are caused by various fungi, bacteria, and viruses and can be life-threatening sometimes. Diseases and disorders associated with infections are triggered by certain organisms that require early diagnosis so that they can be healed before spreading to multiple parts of the body. Viral clearance becomes useful since it removes viral contamination utilizing membranes or chromatography.
  • Increasing Cases of Chronic Disease
  • According to the Centers for Disease Control and Prevention, it was noticed that 6 in 10 Americans have at least 1 chronic disease.
  • Rising Demand for Viral Clearance in Non-Communicable Diseases
  • World Health Organization (WHO) stated that non-communicable diseases cause nearly 17.9 million people per year.
  • Significant Increment in the Number of Viral Fevers
  • For instance, more than 150 million dengue virus infections are diagnosed every year across the globe.


  • Long-Lasting Development Procedure for Drug Discovery
  • Lack of the Requisite Medical Workforce
  • Requirement for Higher Initial Investment

Viral Clearance Segmentation

End-user (CROs, Pharmaceuticals, Biotechnology Company)

The global viral clearance market is segmented and analyzed for demand and supply by end-user into CROs, pharmaceuticals, and biotechnology company, out of which, the CROs segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising investment in the R&D of new medical technology and medicine. For instance, the total spending on medicine across the world is evaluated at around USD 1 trillion in 2021.

Our in-depth analysis of the global market includes the following segments:

       By Method

  • Viral Inactivation
  • Viral Removal

       By Application

  • Blood
  • Recombination
  • Vaccine

        By End-User

  • CROs
  • Pharmaceuticals
  • Biotechnology Company

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Viral Clearance Industry - Regional Synopsis

Regionally, the global viral clearance market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in the North America region is projected to hold the largest market share by the end of 2033. The growth of the market in the region can be ascribed to the presence of major key players in the region and the escalation in number of drug approval. As of 2021, nearly 48 novel drugs were approved by the United States Federal Drug Association (FDA) which was an increase from the recent decade when 24 drugs were being approved per year. Moreover, a higher number of CROs facilitating clinical and preclinical services is further estimated to hike the growth of the market during the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Viral Clearance Landscape

    • Labor Dr. Merk & Kollegen GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Texcell Inc.
    • Merck KGaA
    • Charles River Laboratories, Inc.
    • Sartorius AG
    • SGS AG
    • Syngene International Limited
    • Lonza AG
    • Kedrion S. p. A.
    • Merieux NutriSciences Corporation


In The News

  • Charles River Laboratories, Inc. to launch a new service, AccuPedia. This is referred to as a new informational database that provides a deeper and enhanced look into microorganisms. AccuPedia also assists healthcare providers to make confident operational decisions based on the characteristics of microflora.
  • Texcell Inc. to organize the Viral Safety Days series for the first time. The company is hosting three national events for scientific discussion, networking, presentation, and others. Topics such as, purification to regulatory, therapeutics, and antibodies for gene therapies will be included.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3939
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of chronic disease and a significant increment in the number of viral fevers are estimated to majorly boost market growth.

The market is anticipated to attain a CAGR of 20% over the forecast period, i.e., 2023-2033.

Long-lasting development procedure for drug discovery and the lack of the requisite medical workforce is estimated to challenge the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Texcell Inc., Merck KGaA, Charles River Laboratories, Inc., Sartorius AG, SGS AG, Syngene International Limited, Lonza AG, Kedrion S. p. A., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by method, application, end-user, and by region.

The CROs segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Viral Clearance Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying